Abbott | ABT - Ativos





Ativos Alterar Data
Abbott USD 108.25B 968M 2026-09
Agilent USD 13.97B 902M 2026-06
AtriCure USD 717.54M 40.89M 2026-09
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Bio-Rad Laboratories USD 10.78B 531.1M 2026-09
Boston Scientific USD 45.46B 245M 2026-09
Cooper Companies USD 12.67B 191.1M 2026-06
Danaher USD 93.28B 914M 2026-09
Dexcom USD 6.24B 216.5M 2026-09
Edwards Lifesciences USD 14.14B 277.3M 2026-09
Globus Medical USD 5.53B 39.93M 2026-09
Insulet USD 3.42B 250M 2026-09
Integra LifeSciences USD 3.51B 55.69M 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merit Medical Systems USD 2.92B 61.29M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Smith & Nephew USD 11.01B 321M 2026-06
Solventum Corp USD 14.16B 78M 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.16B 5.29M 2026-09
Teleflex USD 6.35B 438.92M 2026-09
Terumo JPY 2.37T 61.86B 2026-06
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09